StockData
CG Oncology, Inc. logo

CG Oncology, Inc. (CGON) shareholders

CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$74.40+4.25 (+6.06%)

Close on Nov 13, 2026Market cap $6.59BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
94M of 89M shares
Institutional holders
227
34 new, 37 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
1 buys · 17 sales
Net bought $19.98M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
RTW Investments, LP
Joint filing with Roderick Wong (9.70%)
8,514,5909.70%13G (passive) amendmentJun 30, 2026
T. Rowe Price Investment Management, Inc.6,720,3898.00%13G (passive)Mar 31, 2026
Xiangmin Cui
Joint filing with Decheng Capital Global Life Sciences Fund IV, L.P. (7.00%), Decheng Capital Management IV (Cayman), LLC (7.00%)
6,371,6698.40%13G (passive) amendmentDec 31, 2024
BlackRock, Inc.6,023,6966.80%13G (passive) amendmentJun 30, 2026
Wellington Management Company LLP
Joint filing with Wellington Management Group LLP (7.20%), Wellington Group Holdings LLP (7.20%) and 1 more
5,512,7796.90%13G (passive)Sep 30, 2025
Wellington Management Group LLP
Joint filing with Wellington Group Holdings LLP (6.00%), Wellington Investment Advisors Holdings LLP (6.00%) and 1 more
5,324,7516.00%13G (passive) amendmentJun 30, 2026
Juliet Tammenoms Bakker
Joint filing with Patrick G. Enright (6.00%)
4,662,2686.00%13D (active)Sep 11, 2025
SONG, Hong Fang4,211,3415.50%13G (passive) amendmentDec 31, 2024
FMR LLC
Joint filing with Abigail P. Johnson (5.10%)
3,856,2615.10%13G (passive)Jun 30, 2025
Kissei Pharmaceutical Co., Ltd.3,543,5335.30%13G (passive)Jan 29, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CGONValueChange% of portfolio
Rtw Investments, LP8,514,5909.61%$604.96M+1,529,7825.16%
T. Rowe Price Investment Management, Inc.6,616,8997.46%$470.13M−103,4900.31%
Decheng Capital LLC6,371,6697.19%$452.71M–61.87%
BlackRock, Inc.6,256,2887.06%$444.51M+1,192,1080.01%
Wellington Management Group Llp5,324,7516.01%$378.32M−46,4810.07%
FMR LLC4,161,4934.69%$295.67M+396,6490.01%
Price T Rowe Associates Inc /Md/3,805,0104.29%$270.35M+152,0300.03%
TCG Crossover Management, LLC3,670,2064.14%$260.77M–6.27%
Vanguard Portfolio Management LLC3,465,1973.91%$246.20M+370,0990.01%
State Street Corp3,437,5903.88%$244.24M+790,5360.01%
Vanguard Capital Management LLC3,316,7933.74%$235.66M+283,1680.01%
Foresite Capital Management VI LLC2,369,5742.67%$168.36M+148,10026.20%
Geode Capital Management, LLC2,153,2772.43%$153.02M+556,4130.01%
Seven Fleet Capital Management LP1,886,2362.13%$134.02M+1,810,47822.12%
EcoR1 Capital, LLC1,494,3001.69%$106.17M+392,3005.16%
DV Trading LLC1,439,3931.62%$102.27M–3.35%
Avidity Partners Management LP1,398,9481.58%$99.40M+110,00015.92%
Alliancebernstein L.P.1,374,1491.55%$93.00M+84,0620.03%
Franklin Resources Inc1,312,8801.48%$93.28M−194,1250.02%
Morgan Stanley1,177,1091.33%$83.63M+656,8960.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202622794M100.0%34 / 9372 / 3714M8M
Q1 202623388M99.7%65 / 8161 / 2325M13M
Q4 202519583M93.3%43 / 7250 / 2014M9M
Q3 202517678M87.9%34 / 5457 / 199M7M
Q2 202516276M85.7%40 / 7629 / 1914M9M
Q1 202514271M79.8%27 / 6233 / 248M3M
Q4 202414066M74.7%37 / 5927 / 1719M5M
Q3 202412152M58.9%26 / 6019 / 1515M4M
Q2 202411143M48.8%32 / 4518 / 1710M6M
Q1 20249639M43.9%96 / 00 / 039M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

328 funds held CGON in Q2 2026, 38% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of CGONValue% of fundAs of
Vanguard Health Care Fund2,860,4283.23%$203.63M0.53%Jul 31, 2026
T. Rowe Price Capital Appreciation Fund2,574,8682.90%$182.94M0.26%Jun 30, 2026
Vanguard Total Stock Market Index Fund2,383,1342.69%$169.32M0.01%Jun 30, 2026
iShares Russell 2000 ETF1,894,0912.14%$134.58M0.16%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1,812,9322.05%$128.81M1.20%Jun 30, 2026
Vanguard Small-Cap Index Fund1,720,0681.94%$122.21M0.06%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.1,114,6951.26%$79.20M0.54%Jun 30, 2026
Vanguard Extended Market Index Fund860,0260.97%$61.10M0.06%Jun 30, 2026
Fidelity Small Cap Index Fund806,8080.91%$57.44M0.17%Jul 31, 2026
Fidelity Small Cap Growth Fund797,4410.90%$56.77M0.65%Jul 31, 2026
T. Rowe Price Mid-Cap Growth Fund, Inc.744,7930.84%$52.92M0.23%Jun 30, 2026
iShares Russell 2000 Growth ETF681,2200.77%$48.40M0.31%Jun 30, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund658,9810.74%$46.82M0.48%Jun 30, 2026
JNL/T. Rowe Price Capital Appreciation Fund593,2620.67%$42.15M0.28%Jun 30, 2026
Small Cap Growth Fund554,4160.63%$39.47M0.71%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Arthur KuanChief Executive Officer, Director200,7630.23%Apr 16, 2026
Isabel KalofonosChief Commercial Officer––Oct 19, 2026
James M. DetoreChief Financial Officer––Apr 16, 2026
Ambaw BelletePresident and COO––Apr 16, 2026
Joshua F. PattersonSee Remarks––Apr 16, 2026
Vijay KasturiChief Medical Officer1,3150.00%Apr 16, 2026
Bob LapetinaSee Remarks––Aug 6, 2025
Corleen M. RocheCFO2,0000.00%Apr 16, 2025
Leonard E. PostDirector0–Oct 19, 2026
James MulayDirector0–Jul 14, 2026
Brian Guan-Chyun LiuDirector1,886,2362.13%Jun 29, 2026
Susan E. GrafDirector––Jun 5, 2026
Victor Edward Tong JrDirector––Jun 5, 2026
Christina RossiDirector––Jun 5, 2026
Hong Fang SongDirector7,039,0777.94%Sep 4, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Leonard E. Post
Director
Oct 15, 2026Sale(10b5-1 plan)−500$62.48$31.24K0
Leonard E. Post
Director
Oct 15, 2026Sale(10b5-1 plan)−500$61.65$30.83K500
Leonard E. Post
Director
Oct 15, 2026Option exercise+1,000$0.60$6001,000
Leonard E. Post
Director
Sep 15, 2026Sale(10b5-1 plan)−1,000$72.98$72.98K0
Leonard E. Post
Director
Sep 15, 2026Option exercise+1,000$0.60$6001,000
Leonard E. Post
Director
Aug 14, 2026Option exercise+1,000$0.60$6001,000
Leonard E. Post
Director
Aug 14, 2026Sale(10b5-1 plan)−1,000$74.54$74.54K0
Leonard E. Post
Director
Jul 15, 2026Option exercise+1,000$0.60$6001,000
Leonard E. Post
Director
Jul 15, 2026Sale(10b5-1 plan)−1,000$71.17$71.17K0
James Mulay
Director
Jul 10, 2026Sale(10b5-1 plan)−24,165$75.16$1.82M0
James Mulay
Director
Jul 10, 2026Option exercise+24,165$26.63$643.51K24,165
Brian Guan-Chyun Liu
Director
Jun 25, 2026Buy+371,085$66.87$24.81M1,886,236
Leonard E. Post
Director
Jun 24, 2026Option exercise+5,000$0.60$3.00K5,000
Leonard E. Post
Director
Jun 24, 2026Sale(10b5-1 plan)−5,000$70.00$350.00K0
Leonard E. Post
Director
Jun 22, 2026Option exercise+5,000$0.60$3.00K5,000
Leonard E. Post
Director
Jun 22, 2026Sale(10b5-1 plan)−5,000$65.00$325.00K0
James Mulay
Director
Jun 15, 2026Sale(10b5-1 plan)−654$60.12$39.32K0
James Mulay
Director
Jun 15, 2026Sale(10b5-1 plan)−1,310$60.12$78.76K0
James Mulay
Director
Jun 15, 2026Option exercise+1,310$12.59$16.49K1,310
James Mulay
Director
Jun 15, 2026Option exercise+654$3.72$2.43K654
Leonard E. Post
Director
Jun 4, 2026Sale(10b5-1 plan)−1,000$54.50$54.50K0
Leonard E. Post
Director
Jun 4, 2026Option exercise+1,000$0.60$6001,000
James Mulay
Director
Apr 17, 2026Sale(10b5-1 plan)−15,600$73.01$1.14M0
James Mulay
Director
Apr 17, 2026Option exercise+15,600$36.63$571.43K15,600
James Mulay
Director
Mar 16, 2026Sale(10b5-1 plan)−1,310$63.50$83.19K0
James Mulay
Director
Mar 16, 2026Sale(10b5-1 plan)−654$63.50$41.53K0
James Mulay
Director
Mar 16, 2026Option exercise+654$3.72$2.43K654
James Mulay
Director
Mar 16, 2026Option exercise+1,310$12.59$16.49K1,310
Arthur Kuan
Chief Executive Officer, Director
Mar 12, 2026Option exercise+64,612$1.72$111.13K200,763
Arthur Kuan
Chief Executive Officer, Director
Mar 12, 2026Tax withholding−1,847$60.15$111.10K198,916
Arthur Kuan
Chief Executive Officer, Director
Mar 4, 2026Tax withholding−2,871$61.61$176.88K136,151
Arthur Kuan
Chief Executive Officer, Director
Mar 4, 2026Option exercise+102,871$1.72$176.94K139,022
James Mulay
Director
Jan 9, 2026Option exercise+10,491$12.59$132.08K10,491
James Mulay
Director
Jan 9, 2026Option exercise+654$3.72$2.43K654
James Mulay
Director
Jan 9, 2026Sale(10b5-1 plan)−654$44.16$28.88K0
James Mulay
Director
Jan 9, 2026Sale(10b5-1 plan)−10,491$52.99$555.92K0
Leonard E. Post
Director
Nov 17, 2025Option exercise+1,000$0.60$6001,000
Leonard E. Post
Director
Nov 17, 2025Sale(10b5-1 plan)−1,000$41.43$41.43K0
Leonard E. Post
Director
Oct 13, 2025Option exercise+1,000$0.60$6001,000
Leonard E. Post
Director
Oct 13, 2025Sale(10b5-1 plan)−1,000$43.25$43.25K0
James Mulay
Director
Oct 9, 2025Option exercise+5,903$3.72$21.96K5,903
James Mulay
Director
Oct 9, 2025Sale(10b5-1 plan)−5,903$43.99$259.67K0
Leonard E. Post
Director
Sep 30, 2025Sale(10b5-1 plan)−5,000$40.09$200.45K0
Leonard E. Post
Director
Sep 30, 2025Option exercise+5,000$0.60$3.00K5,000
James Mulay
Director
Sep 29, 2025Sale(10b5-1 plan)−12,755$39.19$499.87K0
James Mulay
Director
Sep 29, 2025Option exercise+12,755$1.82$23.21K12,755
James Mulay
Director
Sep 19, 2025Sale(10b5-1 plan)−3,574$38.99$139.35K0
James Mulay
Director
Sep 19, 2025Option exercise+3,574$1.82$6.50K3,574
James Mulay
Director
Sep 18, 2025Sale(10b5-1 plan)−19,112$39.01$745.56K0
James Mulay
Director
Sep 18, 2025Option exercise+19,112$1.82$34.78K19,112
Leonard E. Post
Director
Sep 15, 2025Option exercise+1,000$0.60$6001,000
Leonard E. Post
Director
Sep 15, 2025Sale(10b5-1 plan)−1,000$35.10$35.10K0
Brian Guan-Chyun Liu
Director
Sep 11, 2025Buy+1,515,151$33.00$50.00M1,515,151
James Mulay
Director
Sep 5, 2025Sale(10b5-1 plan)−12,342$30.47$376.06K14,673
James Mulay
Director
Sep 5, 2025Sale(10b5-1 plan)−4,095$31.42$128.66K10,578
James Mulay
Director
Sep 5, 2025Sale(10b5-1 plan)−7,465$32.64$243.66K3,113
James Mulay
Director
Sep 5, 2025Option exercise+27,015$0.60$16.21K27,015
James Mulay
Director
Sep 5, 2025Sale(10b5-1 plan)−3,113$33.22$103.41K0
Leonard E. Post
Director
Sep 3, 2025Option exercise+1,000$0.60$6001,000
Leonard E. Post
Director
Sep 3, 2025Sale(10b5-1 plan)−1,000$28.00$28.00K0

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
12.57%
9M shares short
Days to cover
11.0
At 1M shares a day
Change since last report
+3.9%
From 9M shares
Short volume, 20 days
56.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of CG Oncology's stock actually held short. Settlement fails (shares not delivered on time) peaked at 129,916 shares on Sep 2, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Leonard E. Post
Director
Oct 15, 20263,000$185.52KOct 15, 2026Exercise of Stock Options
Ambaw Bellete
Officer
Sep 21, 202630,787$2.34MSep 21, 2026Stock Option Exercise
Ambaw Bellete
Officer
Sep 17, 20266,532$499.70KSep 17, 2026Stock Option Exercise
Ambaw Bellete
Officer
Sep 11, 2026826$61.95KSep 11, 2026Stock Option Exercise
Ambaw Bellete
Officer
Sep 2, 202629,630$2.30MSep 2, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 31, 202650,000$3.78MAug 31, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 27, 20265,789$459.56KAug 27, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 25, 202610,551$839.34KAug 25, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 24, 20265,762$458.19KAug 24, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 19, 2026100,000$7.95MAug 19, 2026Exercised Shares
Ambaw Bellete
Officer
Aug 17, 202652,438$4.03MAug 17, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 14, 202619,364$1.45MAug 14, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 13, 202625,989$1.97MAug 13, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 12, 202632,137$2.53MAug 12, 2026Stock Option Exercise
Ambaw Bellete
Officer
Aug 11, 202650,000$3.81MAug 11, 2026Stock Option Exercise

See a number that looks wrong?